Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 22, 2021

View Archived Issues

RET inhibitor SYHA-1815 induces G1 cell cycle arrest through c-MYC downregulation

Chiesi identifies new discoidin domain-containing receptor inhibitors

Histone-lysine N-methyltransferase 2A inhibitors discovered at Novartis

Esteve patents dual CACNA2D1/SIGMAR1 ligands

Nanjing Chia Tai Tianqing Pharmaceutical divulges AXL inhibitors

New dihydroorotate dehydrogenase inhibitors described by Medshine Discovery

CD123 x CD3 bispecific Dart molecule MGD-024 active with other agents in AML models

OAB-14 restores dysfunction of endosomal-autophagic-lysosomal pathway in APP/PS1 mice

Discovery of a familial intracranial aneurysm gene

Discovery of novel chalcone derivatives for the treatment of neurodegenerative disorders

PSMA-targeted docetaxel conjugate with high antitumor activity and improved toxicity and solubility

IL-27-producing natural regulatory B-1a cells protect from CNS autoimmune diseases

R-107 improves multiorgan functioning in a sheep model of sepsis

Alnylam submits CTA in U.K. for ALN-XDH to treat gout

CIRBP as promising biomarker to identify high-risk patients with IPF

HPIs show promise for treating herpes simplex viral infection in a murine model

Sorriso closes Series A financing to advance pipeline for immune-mediated diseases

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.